These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 11153768)

  • 1. Molecular effects of HMG-CoA reductase inhibitors on smooth muscle cell proliferation.
    Skaletz-Rorowski A; Eschert H; Pawlus E; Breithardt G
    J Am Coll Cardiol; 2001 Jan; 37(1):337-8. PubMed ID: 11153768
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of HMG-CoA reductase inhibitors on extracellular matrix expression in human vascular smooth muscle cells.
    Riessen R; Axel DI; Fenchel M; Herzog UU; Rossmann H; Karsch KR
    Basic Res Cardiol; 1999 Oct; 94(5):322-32. PubMed ID: 10543307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions between HMG-CoA reductase inhibition and UVB irradiation on proliferation and apoptosis in SM1 smooth muscle cells.
    Unlu S; Mason CD; Schachter M; Hughes AD
    Biochem Soc Trans; 1998 Nov; 26(4):S322. PubMed ID: 10047836
    [No Abstract]   [Full Text] [Related]  

  • 4. Differences in the effects of HMG-CoA reductase inhibitors on proliferation and viability of smooth muscle cells in culture.
    Sindermann JR; Fan L; Weigel KA; Troyer D; Müller JG; Schmidt A; March KL; Breithardt G
    Atherosclerosis; 2000 Jun; 150(2):331-41. PubMed ID: 10856525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of isoprenylation in the inhibitory action of lovastatin on proliferation of SV40 immortalized human saphenous vein smooth muscle cells.
    Unlu S; Mason CD; Hughes AD
    Biochem Soc Trans; 1998 Nov; 26(4):S324. PubMed ID: 10047838
    [No Abstract]   [Full Text] [Related]  

  • 6. Action of an HMG CoA reductase inhibitor, lovastatin, on apoptosis of untransformed and ts-SV40 transformed human smooth muscle cells derived from saphenous vein.
    Unlu S; Clunn G; Schachter M; Demoliou-Mason C; Hughes AD
    J Cardiovasc Pharmacol; 2001 Aug; 38(2):161-73. PubMed ID: 11483865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HMG-CoA reductase inhibition reduces the proinflammatory activation of human vascular smooth muscle cells by the terminal complement factor C5b-9.
    Viedt C; Shen W; Fei J; Kamimura M; Hänsch GM; Katus HA; Kreuzer J
    Basic Res Cardiol; 2003 Nov; 98(6):353-61. PubMed ID: 14556080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of HMG-CoA reductase inhibition on PDGF- and angiotensin II- mediated signal transduction: suppression of c-Jun and c-Fos in human smooth muscle cells in vitro.
    Kreuzer J; Watson L; Herdegen T; Loebe M; Wende P; Kübler K
    Eur J Med Res; 1999 Apr; 4(4):135-43. PubMed ID: 10205288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lovastatin induces p21WAF1/Cip1 in human vascular smooth muscle cells: influence on protein phosphorylation, cell cycle, induction of apoptosis, and growth inhibition.
    Müller C; Kiehl MG; van de Loo J; Koch OM
    Int J Mol Med; 1999 Jan; 3(1):63-8. PubMed ID: 9864387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of proliferation of human smooth muscle cells by various HMG-CoA reductase inhibitors; comparison with other human cell types.
    Nègre-Aminou P; van Vliet AK; van Erck M; van Thiel GC; van Leeuwen RE; Cohen LH
    Biochim Biophys Acta; 1997 Apr; 1345(3):259-68. PubMed ID: 9150246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potent suppression of proliferation of a10 vascular smooth muscle cells by combined treatment with lovastatin and 3-allylfarnesol, an inhibitor of protein farnesyltransferase.
    Mattingly RR; Gibbs RA; Menard RE; Reiners JJ
    J Pharmacol Exp Ther; 2002 Oct; 303(1):74-81. PubMed ID: 12235235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lovastatin blocks basic fibroblast growth factor-induced mitogen-activated protein kinase signaling in coronary smooth muscle cells via phosphatase inhibition.
    Skaletz-Rorowski A; Müller JG; Kroke A; Waltenberger J; Pulawski E; Pinkernell K; Breithardt G
    Eur J Cell Biol; 2001 Mar; 80(3):207-12. PubMed ID: 11322384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HMG CoA reductase inhibitors affect the fibrinolytic system of human vascular cells in vitro: a comparative study using different statins.
    Wiesbauer F; Kaun C; Zorn G; Maurer G; Huber K; Wojta J
    Br J Pharmacol; 2002 Jan; 135(1):284-92. PubMed ID: 11786505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lovastatin inhibits gap junctional communication in cultured aortic smooth muscle cells.
    Shen J; Wang LH; Zheng LR; Zhu JH; Hu SJ
    J Cardiovasc Pharmacol Ther; 2010 Sep; 15(3):296-302. PubMed ID: 20601591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HMG-CoA reductase inhibitor suppression of glomerular cell proliferation in rats with anti-Thy-1.1 nephritis.
    Nabeshima K; Inui K; Uda S; Sugenoya Y; Iwasaki S; Ideura T; Yoshimura A
    Contrib Nephrol; 1997; 120():153-9. PubMed ID: 9257058
    [No Abstract]   [Full Text] [Related]  

  • 16. Tocotrienols potentiate lovastatin-mediated growth suppression in vitro and in vivo.
    McAnally JA; Gupta J; Sodhani S; Bravo L; Mo H
    Exp Biol Med (Maywood); 2007 Apr; 232(4):523-31. PubMed ID: 17392488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HMG-CoA reductase inhibition improves endothelial cell function and inhibits smooth muscle cell proliferation in human saphenous veins.
    Yang Z; Kozai T; van der Loo B; Viswambharan H; Lachat M; Turina MI; Malinski T; Lüscher TF
    J Am Coll Cardiol; 2000 Nov; 36(5):1691-7. PubMed ID: 11079678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lovastatin-induced proliferation inhibition and apoptosis in C6 glial cells.
    Choi JW; Jung SE
    J Pharmacol Exp Ther; 1999 Apr; 289(1):572-9. PubMed ID: 10087052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lovastatin prevents angiotensin II-induced cardiac hypertrophy in cultured neonatal rat heart cells.
    Oi S; Haneda T; Osaki J; Kashiwagi Y; Nakamura Y; Kawabe J; Kikuchi K
    Eur J Pharmacol; 1999 Jul; 376(1-2):139-48. PubMed ID: 10440099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HMG-CoA reductase inhibitors decrease CD11b expression and CD11b-dependent adhesion of monocytes to endothelium and reduce increased adhesiveness of monocytes isolated from patients with hypercholesterolemia.
    Weber C; Erl W; Weber KS; Weber PC
    J Am Coll Cardiol; 1997 Nov; 30(5):1212-7. PubMed ID: 9350917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.